| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.30e-08 | 9 | 14 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 3.00e-05 | 12 | 14 | 2 | GO:0045295 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 7.34e-05 | 120 | 14 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.04e-04 | 739 | 14 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.73e-04 | 187 | 14 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 4.90e-04 | 560 | 14 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 5.10e-04 | 566 | 14 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 6.16e-04 | 53 | 14 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.16e-03 | 1244 | 14 | 5 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.28e-03 | 1271 | 14 | 5 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.48e-03 | 753 | 14 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.05e-03 | 1412 | 14 | 5 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.37e-03 | 1459 | 14 | 5 | GO:0000977 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 2.58e-03 | 875 | 14 | 4 | GO:0019904 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.77e-03 | 417 | 14 | 3 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 7.05e-03 | 582 | 14 | 3 | GO:0140297 | |
| GeneOntologyMolecularFunction | histone binding | 1.44e-02 | 265 | 14 | 2 | GO:0042393 | |
| GeneOntologyBiologicalProcess | multicellular organism growth | 1.89e-05 | 249 | 14 | 4 | GO:0035264 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 6.81e-08 | 13 | 14 | 3 | GO:1990907 | |
| GeneOntologyCellularComponent | chromatin | 1.94e-05 | 1480 | 14 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | transcription regulator complex | 5.21e-04 | 596 | 14 | 4 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 7.13e-04 | 272 | 14 | 3 | GO:0090575 | |
| GeneOntologyCellularComponent | PML body | 3.08e-03 | 125 | 14 | 2 | GO:0016605 | |
| Domain | CTNNB1-bd_N | 1.34e-09 | 4 | 14 | 3 | IPR013558 | |
| Domain | TCF/LEF | 1.34e-09 | 4 | 14 | 3 | IPR024940 | |
| Domain | CTNNB1_binding | 1.34e-09 | 4 | 14 | 3 | PF08347 | |
| Domain | - | 6.59e-08 | 55 | 14 | 4 | 1.10.30.10 | |
| Domain | HMG_box_dom | 1.30e-07 | 65 | 14 | 4 | IPR009071 | |
| Domain | Catenin_binding_dom | 1.21e-06 | 29 | 14 | 3 | IPR027397 | |
| Domain | - | 1.21e-06 | 29 | 14 | 3 | 4.10.900.10 | |
| Domain | HMG_box | 7.68e-06 | 53 | 14 | 3 | PF00505 | |
| Domain | HMG | 8.13e-06 | 54 | 14 | 3 | SM00398 | |
| Domain | HMG_BOX_2 | 8.13e-06 | 54 | 14 | 3 | PS50118 | |
| Domain | RING | 2.13e-02 | 305 | 14 | 2 | SM00184 | |
| Domain | Znf_RING | 2.41e-02 | 326 | 14 | 2 | IPR001841 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 7.06e-09 | 6 | 11 | 3 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 7.06e-09 | 6 | 11 | 3 | M47736 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 1.24e-08 | 7 | 11 | 3 | M47465 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 1.98e-08 | 8 | 11 | 3 | M47413 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 1.98e-08 | 8 | 11 | 3 | MM17229 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 1.98e-08 | 8 | 11 | 3 | M27821 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 1.98e-08 | 8 | 11 | 3 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 4.23e-08 | 10 | 11 | 3 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 4.23e-08 | 10 | 11 | 3 | MM15156 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 7.75e-08 | 12 | 11 | 3 | M47410 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.28e-07 | 14 | 11 | 3 | M27402 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.97e-07 | 16 | 11 | 3 | MM17241 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 2.39e-07 | 17 | 11 | 3 | M39443 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 2.39e-07 | 17 | 11 | 3 | M48240 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 9.10e-07 | 26 | 11 | 3 | MM14793 | |
| Pathway | KEGG_THYROID_CANCER | 1.28e-06 | 29 | 11 | 3 | M523 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.73e-06 | 32 | 11 | 3 | MM14975 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 2.71e-06 | 37 | 11 | 3 | M47411 | |
| Pathway | WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING | 2.71e-06 | 37 | 11 | 3 | M39817 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 3.18e-06 | 39 | 11 | 3 | MM17226 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.99e-06 | 42 | 11 | 3 | M27272 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 4.93e-06 | 45 | 11 | 3 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 5.27e-06 | 46 | 11 | 3 | M47409 | |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 7.65e-06 | 52 | 11 | 3 | M19877 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 9.07e-06 | 55 | 11 | 3 | M17807 | |
| Pathway | WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES | 1.01e-05 | 57 | 11 | 3 | M39877 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 1.01e-05 | 57 | 11 | 3 | M19888 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.30e-05 | 62 | 11 | 3 | M27321 | |
| Pathway | KEGG_COLORECTAL_CANCER | 1.30e-05 | 62 | 11 | 3 | M14631 | |
| Pathway | WP_ENDOMETRIAL_CANCER | 1.37e-05 | 63 | 11 | 3 | M39623 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.72e-05 | 68 | 11 | 3 | M48322 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 2.13e-05 | 73 | 11 | 3 | M39758 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 2.13e-05 | 73 | 11 | 3 | M638 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.22e-05 | 74 | 11 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.22e-05 | 74 | 11 | 3 | M16376 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 2.41e-05 | 76 | 11 | 3 | MM15520 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 2.71e-05 | 79 | 11 | 3 | MM14754 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 2.81e-05 | 80 | 11 | 3 | M223 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 3.37e-05 | 85 | 11 | 3 | M27079 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 3.87e-05 | 89 | 11 | 3 | M39563 | |
| Pathway | KEGG_PROSTATE_CANCER | 3.87e-05 | 89 | 11 | 3 | M13191 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 4.14e-05 | 91 | 11 | 3 | M27101 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 4.70e-05 | 95 | 11 | 3 | M48268 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 4.85e-05 | 96 | 11 | 3 | M27784 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 5.16e-05 | 98 | 11 | 3 | M39731 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 5.16e-05 | 98 | 11 | 3 | M39830 | |
| Pathway | KEGG_MELANOGENESIS | 5.65e-05 | 101 | 11 | 3 | M7761 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 5.65e-05 | 101 | 11 | 3 | M39387 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 5.97e-05 | 301 | 11 | 4 | MM15983 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 7.29e-05 | 110 | 11 | 3 | M39492 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 7.90e-05 | 113 | 11 | 3 | M39669 | |
| Pathway | REACTOME_GASTRULATION | 1.17e-04 | 129 | 11 | 3 | M46433 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.40e-04 | 137 | 11 | 3 | M48232 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.66e-04 | 768 | 11 | 5 | MM14851 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 1.69e-04 | 146 | 11 | 3 | M27288 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.87e-04 | 151 | 11 | 3 | M19428 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.98e-04 | 154 | 11 | 3 | M39739 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 2.13e-04 | 158 | 11 | 3 | MM14791 | |
| Pathway | WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA | 3.63e-04 | 37 | 11 | 2 | M39756 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 4.46e-04 | 41 | 11 | 2 | M29748 | |
| Pathway | REACTOME_CA2_PATHWAY | 5.38e-04 | 45 | 11 | 2 | MM15040 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 5.87e-04 | 47 | 11 | 2 | M236 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 6.33e-04 | 1022 | 11 | 5 | MM15436 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 6.67e-04 | 233 | 11 | 3 | M27099 | |
| Pathway | WP_WNT_SIGNALING_WP363 | 6.91e-04 | 51 | 11 | 2 | M39721 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 7.18e-04 | 239 | 11 | 3 | MM14756 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 1.75e-03 | 325 | 11 | 3 | M12868 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.82e-03 | 330 | 11 | 3 | M7847 | |
| Pathway | WNT_SIGNALING | 2.09e-03 | 89 | 11 | 2 | M5493 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 2.55e-03 | 1387 | 11 | 5 | M734 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 2.68e-03 | 101 | 11 | 2 | MM15829 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.94e-03 | 123 | 11 | 2 | MM14988 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 4.11e-03 | 439 | 11 | 3 | M42563 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 5.29e-03 | 143 | 11 | 2 | M39591 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.98e-03 | 502 | 11 | 3 | MM14537 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 6.04e-03 | 153 | 11 | 2 | M39546 | |
| Pathway | WP_CANCER_PATHWAYS | 6.15e-03 | 507 | 11 | 3 | M48302 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.57e-02 | 252 | 11 | 2 | MM15585 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.95e-02 | 1432 | 11 | 4 | M509 | |
| Pubmed | 5.19e-11 | 3 | 14 | 3 | 34525377 | ||
| Pubmed | 5.19e-11 | 3 | 14 | 3 | 32403323 | ||
| Pubmed | 2.08e-10 | 4 | 14 | 3 | 33587034 | ||
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 2.08e-10 | 4 | 14 | 3 | 17065530 | |
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 5.19e-10 | 5 | 14 | 3 | 21285352 | |
| Pubmed | 1.04e-09 | 6 | 14 | 3 | 9488439 | ||
| Pubmed | 1.04e-09 | 6 | 14 | 3 | 23152144 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 1.04e-09 | 6 | 14 | 3 | 19304756 | |
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 1.82e-09 | 7 | 14 | 3 | 32820720 | |
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 1.82e-09 | 7 | 14 | 3 | 18772112 | |
| Pubmed | 1.82e-09 | 7 | 14 | 3 | 19303461 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 4.36e-09 | 9 | 14 | 3 | 17335794 | |
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 8.55e-09 | 11 | 14 | 3 | 11731265 | |
| Pubmed | Tcf7L2 is essential for neurogenesis in the developing mouse neocortex. | 8.55e-09 | 11 | 14 | 3 | 29751817 | |
| Pubmed | 1.14e-08 | 12 | 14 | 3 | 32414917 | ||
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 1.14e-08 | 12 | 14 | 3 | 10631168 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.14e-08 | 12 | 14 | 3 | 11266540 | |
| Pubmed | 1.88e-08 | 14 | 14 | 3 | 15226261 | ||
| Pubmed | 1.88e-08 | 14 | 14 | 3 | 33195246 | ||
| Pubmed | Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. | 1.88e-08 | 14 | 14 | 3 | 10090727 | |
| Pubmed | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. | 2.36e-08 | 15 | 14 | 3 | 15866165 | |
| Pubmed | Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. | 2.36e-08 | 15 | 14 | 3 | 17681174 | |
| Pubmed | Mutant Lef1 controls Gata6 in sebaceous gland development and cancer. | 2.90e-08 | 16 | 14 | 3 | 30886049 | |
| Pubmed | Wnt/β-catenin signaling in the dental mesenchyme regulates incisor development by regulating Bmp4. | 5.01e-08 | 19 | 14 | 3 | 20883686 | |
| Pubmed | Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction. | 5.90e-08 | 20 | 14 | 3 | 22573616 | |
| Pubmed | Sequential roles of Hedgehog and Wnt signaling in osteoblast development. | 5.90e-08 | 20 | 14 | 3 | 15576404 | |
| Pubmed | Tcf7l1 protects the anterior neural fold from adopting the neural crest fate. | 6.88e-08 | 21 | 14 | 3 | 27302397 | |
| Pubmed | 7.96e-08 | 22 | 14 | 3 | 17919533 | ||
| Pubmed | Dentate gyrus morphogenesis is regulated by β-catenin function in hem-derived fimbrial glia. | 1.19e-07 | 25 | 14 | 3 | 36196585 | |
| Pubmed | 1.34e-07 | 26 | 14 | 3 | 25810530 | ||
| Pubmed | Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. | 1.50e-07 | 2 | 14 | 2 | 11445543 | |
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 1.50e-07 | 2 | 14 | 2 | 9916915 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 10498690 | ||
| Pubmed | Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. | 1.50e-07 | 2 | 14 | 2 | 21599871 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 23224985 | ||
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 1.50e-07 | 2 | 14 | 2 | 1741298 | |
| Pubmed | 1.51e-07 | 27 | 14 | 3 | 23824573 | ||
| Pubmed | 1.51e-07 | 27 | 14 | 3 | 25885041 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 4.00e-07 | 37 | 14 | 3 | 35831952 | |
| Pubmed | 4.00e-07 | 37 | 14 | 3 | 15342465 | ||
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 4.34e-07 | 38 | 14 | 3 | 18635608 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 17607356 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 25659031 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 14661054 | ||
| Pubmed | In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators. | 4.51e-07 | 3 | 14 | 2 | 24463605 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 34001234 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 12446687 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 20532534 | ||
| Pubmed | Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation. | 4.51e-07 | 3 | 14 | 2 | 21282610 | |
| Pubmed | Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. | 8.33e-07 | 47 | 14 | 3 | 16678101 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 15684397 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 12556497 | ||
| Pubmed | TCF transcription factors: molecular switches in carcinogenesis. | 9.02e-07 | 4 | 14 | 2 | 10528152 | |
| Pubmed | Pja2 Inhibits Wnt/β-catenin Signaling by Reducing the Level of TCF/LEF1. | 9.02e-07 | 4 | 14 | 2 | 30021253 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 18202148 | ||
| Pubmed | 1.42e-06 | 56 | 14 | 3 | 19591821 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 15525529 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 11731231 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 12408825 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 16714285 | ||
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 2.25e-06 | 6 | 14 | 2 | 24748645 | |
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 2.25e-06 | 6 | 14 | 2 | 20128911 | |
| Pubmed | 3.01e-06 | 263 | 14 | 4 | 20932939 | ||
| Pubmed | 3.16e-06 | 7 | 14 | 2 | 16678815 | ||
| Pubmed | The Wnt/beta-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis. | 3.16e-06 | 7 | 14 | 2 | 16936075 | |
| Pubmed | 3.16e-06 | 7 | 14 | 2 | 16204248 | ||
| Pubmed | Wnt signaling mediates regional specification in the vertebrate face. | 4.21e-06 | 8 | 14 | 2 | 17699607 | |
| Pubmed | 4.21e-06 | 8 | 14 | 2 | 21177349 | ||
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 4.21e-06 | 8 | 14 | 2 | 32179550 | |
| Pubmed | 5.97e-06 | 709 | 14 | 5 | 22988430 | ||
| Pubmed | A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. | 6.76e-06 | 10 | 14 | 2 | 22393260 | |
| Pubmed | Tcf3 expression marks both stem and progenitor cells in multiple epithelia. | 6.76e-06 | 10 | 14 | 2 | 25038042 | |
| Pubmed | 8.26e-06 | 11 | 14 | 2 | 21452227 | ||
| Pubmed | 9.91e-06 | 12 | 14 | 2 | 26333992 | ||
| Pubmed | TCF/Lef1-mediated control of lipid metabolism regulates skin barrier function. | 9.91e-06 | 12 | 14 | 2 | 21938009 | |
| Pubmed | Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion. | 9.91e-06 | 12 | 14 | 2 | 19700620 | |
| Pubmed | 1.12e-05 | 808 | 14 | 5 | 20412781 | ||
| Pubmed | Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. | 1.17e-05 | 13 | 14 | 2 | 19718027 | |
| Pubmed | Investigation of genes important in neurodevelopment disorders in adult human brain. | 1.17e-05 | 13 | 14 | 2 | 26194112 | |
| Pubmed | 1.37e-05 | 14 | 14 | 2 | 17360773 | ||
| Pubmed | Loss of Axin2 Causes Ocular Defects During Mouse Eye Development. | 1.58e-05 | 15 | 14 | 2 | 27701636 | |
| Pubmed | The apical ectodermal ridge is a timer for generating distal limb progenitors. | 1.58e-05 | 15 | 14 | 2 | 18359901 | |
| Pubmed | 1.58e-05 | 15 | 14 | 2 | 15713628 | ||
| Pubmed | Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. | 1.80e-05 | 16 | 14 | 2 | 19487454 | |
| Pubmed | Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos. | 1.80e-05 | 16 | 14 | 2 | 15057272 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.97e-05 | 908 | 14 | 5 | 19274049 | |
| Pubmed | Different roles of Runx2 during early neural crest-derived bone and tooth development. | 2.04e-05 | 17 | 14 | 2 | 16813524 | |
| Pubmed | Notch Signaling Pathway in Tooth Shape Variations throughout Evolution. | 2.29e-05 | 18 | 14 | 2 | 36899896 | |
| Pubmed | 2.29e-05 | 18 | 14 | 2 | 22166339 | ||
| Pubmed | Mi-2/NuRD is required in renal progenitor cells during embryonic kidney development. | 2.29e-05 | 18 | 14 | 2 | 23201013 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 2.33e-05 | 442 | 14 | 4 | 15815621 | |
| Pubmed | Molecular functions of the TLE tetramerization domain in Wnt target gene repression. | 2.56e-05 | 19 | 14 | 2 | 24596249 | |
| Pubmed | 2.56e-05 | 19 | 14 | 2 | 20219685 | ||
| Pubmed | hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells. | 2.56e-05 | 19 | 14 | 2 | 35739118 | |
| Pubmed | Fuz regulates craniofacial development through tissue specific responses to signaling factors. | 2.85e-05 | 20 | 14 | 2 | 21935430 | |
| Pubmed | 2.88e-05 | 152 | 14 | 3 | 11044609 | ||
| Pubmed | 3.15e-05 | 21 | 14 | 2 | 25114215 | ||
| Pubmed | MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus. | 3.46e-05 | 22 | 14 | 2 | 34032267 | |
| Pubmed | TCF7L2 regulates postmitotic differentiation programmes and excitability patterns in the thalamus. | 3.46e-05 | 22 | 14 | 2 | 32675279 | |
| Pubmed | 3.46e-05 | 22 | 14 | 2 | 21775418 | ||
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 6.03e-07 | 1102 | 14 | 7 | M2369 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | 6.89e-07 | 1124 | 14 | 7 | MM1070 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 4.51e-05 | 19 | 14 | 2 | M16026 | |
| Coexpression | ZHONG_PFC_C4_PTGDS_POS_OPC | 6.01e-05 | 147 | 14 | 3 | M39099 | |
| Coexpression | GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP | 1.48e-04 | 199 | 14 | 3 | M9269 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN | 1.50e-04 | 200 | 14 | 3 | M5081 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 4.34e-05 | 654 | 14 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_500 | 5.63e-05 | 339 | 14 | 4 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 9.37e-05 | 769 | 14 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 1.35e-04 | 831 | 14 | 5 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.90e-04 | 893 | 14 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 2.97e-04 | 983 | 14 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 3.05e-04 | 989 | 14 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_200 | 3.10e-04 | 40 | 14 | 2 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.20e-04 | 210 | 14 | 3 | gudmap_developingGonad_e14.5_ ovary_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.21e-04 | 248 | 14 | 3 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 5.65e-04 | 255 | 14 | 3 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-07 | 196 | 14 | 4 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-05 | 139 | 14 | 3 | 9e9f29f92dbe65b26cc78b3a1c00778c6a701f5b | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 1.94e-05 | 172 | 14 | 3 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.01e-05 | 174 | 14 | 3 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.18e-05 | 179 | 14 | 3 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 188 | 14 | 3 | a37edd8f9e4a4e336b5acbb0407d3d275975cee8 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.53e-05 | 188 | 14 | 3 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 190 | 14 | 3 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 190 | 14 | 3 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 191 | 14 | 3 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 191 | 14 | 3 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 193 | 14 | 3 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 195 | 14 | 3 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.82e-05 | 195 | 14 | 3 | febe746099964b9ea9e75f2efc72c962c01f0421 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 196 | 14 | 3 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 197 | 14 | 3 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-05 | 197 | 14 | 3 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 197 | 14 | 3 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.95e-05 | 198 | 14 | 3 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | distal-3-Endothelial-Artery|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-05 | 199 | 14 | 3 | 7814804f4ecc0655610e5c85f513b3976d856192 | |
| ToppCell | distal-1-Endothelial-Artery|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-05 | 199 | 14 | 3 | fd71d08f6de790a29c880d50d2ed0881952d7791 | |
| ToppCell | distal-Endothelial-Artery-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.99e-05 | 199 | 14 | 3 | 8acf381087268fcf13f025e3b67e028bf1f9b77e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_3|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.04e-05 | 200 | 14 | 3 | 55a1df656545ff078b727d55e4d65d61ddb5c41f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 5.88e-04 | 116 | 14 | 2 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 127 | 14 | 2 | 39fa20a55de3af1a62ab5dfa4877879db3935ac2 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.18e-04 | 137 | 14 | 2 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 8.30e-04 | 138 | 14 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.66e-04 | 141 | 14 | 2 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.15e-04 | 145 | 14 | 2 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | MS-CD8-CD8_2|MS / Condition, Cell_class and T cell subcluster | 9.79e-04 | 150 | 14 | 2 | 01c20d787ce269db0d153e63a600a8d9ead61856 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 152 | 14 | 2 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type | 1.02e-03 | 153 | 14 | 2 | b24c693b142206d13b29c96faa7f79a1a22bc2ef | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-03 | 153 | 14 | 2 | 64d0f37d7af9b76234f683379e3689771f71fe70 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-03 | 153 | 14 | 2 | 5ac4b97d35c1029a5fc625239f92e35136c4d832 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-03 | 154 | 14 | 2 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | URO-Lymphocyte-T_NK-Treg|URO / Disease, Lineage and Cell Type | 1.03e-03 | 154 | 14 | 2 | 73fe0e26088a1b012902cc062ffbb3e4d2ff09f9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-03 | 155 | 14 | 2 | 583cfaa41c755c63aee312eb442e9d97f645d5f7 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-03 | 157 | 14 | 2 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | Control-Lymphocyte-T_NK-dnT|Control / Disease, Lineage and Cell Type | 1.08e-03 | 158 | 14 | 2 | 7a2fad6426549d910834debfe5e102fe2ab5976d | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 158 | 14 | 2 | 72e4f8ae137a7dddee0dc6236532e0711065e6af | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 158 | 14 | 2 | e1a8dba5a88bc3ce112829c5ecb112cbbee5b078 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-MAIT|Bac-SEP / Disease, Lineage and Cell Type | 1.10e-03 | 159 | 14 | 2 | e043c65f3febdfa7f75a67702e92fcdebe144a00 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-03 | 159 | 14 | 2 | 22427ad4ad2e797e4664e7a7b0514094f22a18b2 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-Treg|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.14e-03 | 162 | 14 | 2 | 975d52e3cc101e7592425128e1099d30847a8a42 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.15e-03 | 163 | 14 | 2 | 9195051d6bcdd450ed745a099828a0d76d9d3f0b | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-03 | 164 | 14 | 2 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-03 | 164 | 14 | 2 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-03 | 164 | 14 | 2 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-03 | 164 | 14 | 2 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Naive_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.18e-03 | 165 | 14 | 2 | 34f0394356b96e31b87fb8c2fd323cf7a3f077e3 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-03 | 165 | 14 | 2 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-03 | 165 | 14 | 2 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-03 | 165 | 14 | 2 | c39f0479955c4e23921f7a450d3bc251a002200f | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.18e-03 | 165 | 14 | 2 | ebd668e87e5961a124d1d6fc25d1f03e4af05cd4 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-03 | 165 | 14 | 2 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-03 | 165 | 14 | 2 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-03 | 165 | 14 | 2 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.20e-03 | 166 | 14 | 2 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-03 | 166 | 14 | 2 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-03 | 166 | 14 | 2 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 167 | 14 | 2 | d72b08b3cbc34b30a11dcf512e472b64d1606ec1 | |
| ToppCell | COVID-19_Moderate-Treg|COVID-19_Moderate / disease group, cell group and cell class | 1.21e-03 | 167 | 14 | 2 | 4ddb21421cbe72c06b61dd3a5eb1337e59de42e5 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 167 | 14 | 2 | 22f7384ff2044898d7b0b01cb9d9a3cbaa93a9a3 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 167 | 14 | 2 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-03 | 168 | 14 | 2 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 1.22e-03 | 168 | 14 | 2 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.22e-03 | 168 | 14 | 2 | 5e721268f0baa51d3f640f7f4c41db769ebef210 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-03 | 168 | 14 | 2 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 168 | 14 | 2 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-03 | 168 | 14 | 2 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-03 | 169 | 14 | 2 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | b7db33be24a6a9386e277c2f8949551e4d259305 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-03 | 169 | 14 | 2 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-03 | 169 | 14 | 2 | 81bbdcf1fdf5cad5bfe7a559af196ad0d8e18c35 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-03 | 169 | 14 | 2 | cc1b60eb50a274ffd72c67082c19e43af775e949 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-03 | 169 | 14 | 2 | 89b5452e0d8d058648a1d2659f1611fd6aebc6b6 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-03 | 170 | 14 | 2 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.25e-03 | 170 | 14 | 2 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-03 | 170 | 14 | 2 | bda900c836e0f2c1d7b442beb50b672d025b2420 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-03 | 170 | 14 | 2 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-03 | 171 | 14 | 2 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 171 | 14 | 2 | f08402d0f42822c35673522043b652f8fb68d2f6 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-03 | 171 | 14 | 2 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-03 | 171 | 14 | 2 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-03 | 171 | 14 | 2 | a8adce007ff4c713f71f2359b40cb3575b28c98d | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-03 | 171 | 14 | 2 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-03 | 171 | 14 | 2 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-03 | 171 | 14 | 2 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-03 | 171 | 14 | 2 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 1.28e-03 | 172 | 14 | 2 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 172 | 14 | 2 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.28e-03 | 172 | 14 | 2 | 25bf2551d698237bfd912c2ff067b1600dfb19ca | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 172 | 14 | 2 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-03 | 172 | 14 | 2 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 172 | 14 | 2 | f320813177f246926bfd5862b4e0f9bd828cebab | |
| Drug | stacker | 4.77e-07 | 26 | 14 | 3 | CID000092326 | |
| Drug | CKI-7 | 4.26e-06 | 53 | 14 | 3 | CID000129236 | |
| Drug | Eburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.41e-06 | 190 | 14 | 4 | 7154_DN | |
| Drug | Isoxicam [34552-84-6]; Up 200; 12uM; PC3; HT_HG-U133A | 4.98e-06 | 196 | 14 | 4 | 1820_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 5.08e-06 | 197 | 14 | 4 | 5276_UP | |
| Drug | flurbiprofen | 1.43e-04 | 171 | 14 | 3 | CID000003394 | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.43e-04 | 171 | 14 | 3 | 3318_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.48e-04 | 173 | 14 | 3 | 3464_UP | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | 1.49e-04 | 909 | 14 | 5 | CID000002524 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 1.69e-04 | 181 | 14 | 3 | 1791_DN | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.74e-04 | 183 | 14 | 3 | 6985_UP | |
| Drug | nickel subsulfide | 1.89e-04 | 188 | 14 | 3 | ctd:C017557 | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.92e-04 | 189 | 14 | 3 | 973_UP | |
| Drug | Dietary Carbohydrates | 1.92e-04 | 189 | 14 | 3 | ctd:D004040 | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.92e-04 | 189 | 14 | 3 | 4401_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.95e-04 | 190 | 14 | 3 | 3172_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.98e-04 | 191 | 14 | 3 | 4168_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.98e-04 | 191 | 14 | 3 | 5567_DN | |
| Drug | Butacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.01e-04 | 192 | 14 | 3 | 3469_DN | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 3263_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 5024_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 1464_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 5588_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 3098_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 2.07e-04 | 194 | 14 | 3 | 2469_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A | 2.07e-04 | 194 | 14 | 3 | 3035_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 2.07e-04 | 194 | 14 | 3 | 2221_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 4706_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HG-U133A | 2.10e-04 | 195 | 14 | 3 | 1932_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 7377_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; HL60; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 2719_DN | |
| Drug | 17-AAG; Down 200; 1uM; SKMEL5; HG-U133A | 2.10e-04 | 195 | 14 | 3 | 505_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 5591_DN | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.10e-04 | 195 | 14 | 3 | 3163_DN | |
| Drug | Metixene hydrochloride [1553-34-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 5018_DN | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 5052_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 3567_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 3534_DN | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HG-U133A | 2.13e-04 | 196 | 14 | 3 | 1959_DN | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 5290_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 2229_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 2248_DN | |
| Drug | 5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA | 2.13e-04 | 196 | 14 | 3 | 892_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 5386_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 7329_DN | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 1146_DN | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A | 2.13e-04 | 196 | 14 | 3 | 7298_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 7194_DN | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 1691_UP | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 5320_DN | |
| Drug | Atracurium besylate [64228-81-5]; Up 200; 3.2uM; PC3; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 1824_UP | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 3039_DN | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2282_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 7419_UP | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 3334_UP | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 1695_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 5616_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 6226_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 6169_DN | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 3632_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 6787_DN | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; HL60; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2140_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 3439_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2766_UP | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.16e-04 | 197 | 14 | 3 | 2309_DN | |
| Drug | Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 4837_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5272_UP | |
| Drug | AC1L9NAZ | 2.20e-04 | 198 | 14 | 3 | CID000449606 | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 6827_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5673_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 6019_DN | |
| Drug | Harmane hydrochloride [21655-84-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 2806_UP | |
| Drug | Sulfasalazine [599-79-1]; Up 200; 10uM; HL60; HG-U133A | 2.20e-04 | 198 | 14 | 3 | 1733_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 3356_UP | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 2242_DN | |
| Drug | Betazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 1690_DN | |
| Drug | 5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 2.20e-04 | 198 | 14 | 3 | 889_DN | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 7442_DN | |
| Drug | Lisuride (S)(-) [18016-80-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5028_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 2791_UP | |
| Drug | Karakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 3638_UP | |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 3398_DN | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 5013_DN | |
| Drug | Propranolol hydrochloride [318-98-9]; Down 200; 13.6uM; HL60; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3059_DN | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 4023_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 2765_UP | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 7217_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 6740_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 5988_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 7331_DN | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 2820_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 199 | 14 | 3 | 3346_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 2677_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 1164_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 7129_DN | |
| Drug | Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 4807_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; HL60; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 2954_DN | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 1476_DN | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 200 | 14 | 3 | 6246_UP | |
| Drug | metformin | 3.63e-04 | 235 | 14 | 3 | CID000004091 | |
| Disease | obesity (implicated_via_orthology) | 1.86e-06 | 215 | 13 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | blood phosphate measurement | 5.52e-05 | 174 | 13 | 3 | EFO_0010972 | |
| Disease | urate measurement, bone density | 1.18e-04 | 619 | 13 | 4 | EFO_0003923, EFO_0004531 | |
| Disease | Cardiomyopathy, Dilated | 2.00e-04 | 48 | 13 | 2 | C0007193 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 2.17e-04 | 50 | 13 | 2 | C1449563 | |
| Disease | sitting height ratio | 2.26e-04 | 51 | 13 | 2 | EFO_0007118 | |
| Disease | neuroimaging measurement, brain volume measurement | 2.40e-04 | 286 | 13 | 3 | EFO_0004346, EFO_0006930 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.13e-04 | 60 | 13 | 2 | C4722327 | |
| Disease | Prostate cancer, familial | 4.13e-04 | 69 | 13 | 2 | C2931456 | |
| Disease | neuroimaging measurement | 9.42e-04 | 1069 | 13 | 4 | EFO_0004346 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 9.54e-04 | 105 | 13 | 2 | DOID:9352 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 1.18e-03 | 117 | 13 | 2 | DOID:10283 (is_implicated_in) | |
| Disease | breast cancer (is_implicated_in) | 1.93e-03 | 150 | 13 | 2 | DOID:1612 (is_implicated_in) | |
| Disease | Colonic Neoplasms | 1.98e-03 | 152 | 13 | 2 | C0009375 | |
| Disease | Malignant tumor of colon | 2.16e-03 | 159 | 13 | 2 | C0007102 | |
| Disease | cortical surface area measurement | 2.21e-03 | 1345 | 13 | 4 | EFO_0010736 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.50e-03 | 171 | 13 | 2 | DOID:9352 (is_implicated_in) | |
| Disease | Myocardial Ischemia | 2.64e-03 | 176 | 13 | 2 | C0151744 | |
| Disease | diastolic blood pressure, systolic blood pressure | 2.81e-03 | 670 | 13 | 3 | EFO_0006335, EFO_0006336 | |
| Disease | cervical carcinoma | 2.82e-03 | 182 | 13 | 2 | EFO_0001061 | |
| Disease | Colorectal Carcinoma | 3.21e-03 | 702 | 13 | 3 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| INPKKQRKKKNYKNS | 266 | Q96FN4 | |
| DQVKKRKKKRKDYQP | 71 | Q9P0M2 | |
| GYPEDRKLKKNKKNS | 3941 | Q8TCU4 | |
| NYGKKKKRKREKLQE | 371 | Q9UJU2 | |
| KRQKGKPKRKSKYKI | 956 | Q8IZA0 | |
| DKDKKRQKKRGIFPK | 271 | O14770 | |
| KNKPLDNKGEKRKRK | 1136 | Q7Z6E9 | |
| DPAQPRKYKKKKKEL | 691 | Q12873 | |
| RKYKKKKKELQGDGP | 696 | Q12873 | |
| DKKGFYKKKQCRPSK | 241 | P17936 | |
| YKKERKGKKGVKRPN | 336 | O43815 | |
| RDNYGKKKKRKREKQ | 416 | Q9HCS4 | |
| DNYGKKKKRKRDKQP | 421 | Q9NQB0 | |
| KRKKKKKQDYLQGAP | 1141 | Q9NVE5 | |
| KQKPKKKRRPDSRQY | 391 | P08048 |